Abstract
Individuals who have a germline TP53 mutation have Li‐Fraumeni Syndrome (LFS) and a high risk of cancer‐related morbidity and mortality. Effective cancer risk management is an important issue. A whole‐body (WB) surveillance trial (SMOC) in adults with TP53 mutations has been established to estimate the prevalence and incidence of investigable lesions in these carriers. The psychosocial impact of using WB MRI in individuals with LFS is unknown.
Original language | English |
---|---|
Article number | 329 |
Pages (from-to) | 166-167 |
Number of pages | 2 |
Journal | Asia Pacific Journal of Clinical Oncology |
Volume | 10 |
Issue number | S8 |
DOIs | |
Publication status | Published - 2014 |
Keywords
- cancer
- medical screening
- psychological aspects